ORGANON & CO.
(NYSE: OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

18.780

+0.850 (+4.74%)
Range 17.860 - 19.045   (6.63%)
Open 18.010
Previous Close 17.930
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 3,694,745
Value -
Remark
Delayed prices. Updated at 01 Nov 2024 04:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis